Filter
1939
Filtered Results: 1939
Text search:
Food
and
Drug
Administration
Featured
Recommendations
210
New Publications
554
Language
Document type
No document type
1087
Guidelines
354
Studies & Reports
259
Manuals
109
Strategic & Response Plan
60
Fact sheets
27
Training Material
24
Situation Updates
9
Resource Platforms
3
Infographics
3
Brochures
2
Videos
2
Countries / Regions
India
110
Ethiopia
71
Kenya
66
Global
63
Nigeria
57
Tanzania
53
South Africa
46
Ghana
41
Uganda
39
Liberia
36
Myanmar / Burma
35
Western and Central Europe
34
Nepal
30
Sierra Leone
30
Rwanda
30
Philippines
29
Zambia
29
Bangladesh
24
Latin America and the Carribbean
23
Malawi
18
Eastern Europe
17
Namibia
16
Africa
15
Indonesia
15
Lesotho
13
Zimbabwe
12
Russia
12
USA
11
Cambodia
11
Colombia
10
South Sudan
10
Congo, Democratic Republic of
9
Germany
8
Botswana
8
Ukraine
7
Syria
7
Mozambique
7
West and Central Africa
7
Middle East and North Africa
7
South–East Asia Region
7
Brazil
7
Eswatini/ Swaziland
7
Thailand
5
Cameroon
5
Haiti
5
Eastern Europe and Central Asia
5
Sudan
5
Laos
4
Venezuela
4
Jordan
4
East and Southern Africa
4
Tajikistan
3
Iran
3
Peru
3
Asia
3
Western Pacific Region
3
Paraguay
3
Argentina
3
Papua New Guinea
3
Iraq
3
Somalia
3
Pakistan
3
Timor Leste/ East Timor
2
Turkey
2
Benin
2
Senegal
2
Morocco
2
United Kingdom
2
Vietnam
2
Sri Lanka
2
Yemen
2
Central African Republic
2
Poland
2
Angola
2
Libya
2
Switzerland
1
Mexico
1
El Salvador
1
China
1
Chile
1
Albania
1
Singapore
1
Burkina Faso
1
Afghanistan
1
Qatar
1
Guinea
1
Guinea-Bissau
1
Hungary
1
Lithuania
1
Saudi Arabia
1
North America
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Lebanon
1
Moldova
1
Greece
1
Palestine
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
836
Clinical Guidelines
208
Public Health
83
Women & Child Health
78
Key Resources
66
Pharmacy & Technologies
28
Capacity Building
26
Toolboxes
AMR
141
TB
136
Mental Health
131
COVID-19
122
HIV
121
Pharmacy
92
NTDs
77
Caregiver
47
Ebola & Marburg
36
NCDs
35
Rapid Response
32
Planetary Health
30
Malaria
28
Refugee
26
Conflict
17
Global Health Education
15
Specific Hazards
14
Disability
13
Cholera
12
2.0 Rapid Response
11
Natural Hazards
9
Zika
9
Health Financing Toolbox
7
Polio
6
Social Ethics
4
While infections that develop during hospitalization may appear to be an uncommon but recognized risk of hospital care today, the incidence of these infections has been increasing dramatically during the last 2 to 3 decades, and the risk of acquiring an organism that is resistant to 1 or more antibi...
No publication year indicated
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ...
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ...
Economic Issues, Policies and Option for Action
The document provides a detailed overview of cholera, including its clinical features, diagnosis, treatment, and prevention. It explains the causes of cholera, its symptoms such as severe diarrhea and dehydration, and the importance of rehydration therapy (oral or intravenous) to reduce mortality. T...
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Copenhagen, Denmark, 24–25 August 2017
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
